An AAV vector carrying AAV2 genome and a liver-specific AAV8 capsid (AAV2/8) has been used to deliver murine ACE2 (mACE2) into the liver of three short-term experimental mouse models with liver disease [36]. Here, ACE2 is linked to liver disorder.